|
 Since its formation in 2004, NRG has been committed to investing its resources into the research of the effects and associated outcomes observed with InterX® Therapy as an adjunct to standard rehabilitation.
Since 2005, we have completed a total of 8 Random Controlled Trials (RCT) and 4 Case Studies to examine the following parameters:
- Pain reduction
- Increased range of motion / improvement in function
- Reduction in inflammation
- Reduction of medication
Details of some of these trials can be found on the links on this page to the left. We submitted the first article for publication in May 2007.
NRG continues to explore the physiological effects and mechanisms of action of InterX® Technology.
Direct costs as submitted to NRG via a budget document for staffing, testing, treatment and subject compensation are acceptable expenses and will be paid as well as other mutually agreed upon expenses. As a start-up company it is our policy to pay indirect costs up to a maximum rate of 30% or less.
|
